In The News: New Treatment for Dust Allergies
LUBBOCK, TX (KCBD) -
About 20 million Americans are allergic to dust mites. Those annoying little critters
collect in the home, especially in mattresses and bedding, because they feed off the
skin we shed.
That's the bad news. The good news is that the Food and Drug Administration has approved a breakthrough treatment to fight dust allergies.
It's called Odactra.
Dr. James Tarbox, an Allergist and Texas Tech Physician, says, "This is the first one in America for dust mites. So, it is a big deal."
This treatment is not an injection. It's much easier than that. Instead, Dr. Tarbox
says this is a prescription you can take in your own home. He explains, "And what
you do is you put it under your tongue and it will dissolve every day and after about
8 to 12 weeks, most people will notice a significant improvement in their symptoms."
Dust mite allergies are so common that he says, "20 to 30% of people with allergies are allergic to dust mites." He says it is also good to know that this new treatment has minor, if any side effects. Dr. Tarbox says patients may feel a little itching inside the mouth on the tongue, but nothing serious.
No word yet on when Odactra will be available since it was just FDA approved today on March 2nd.
In the meantime, Dr. Tarbox says you can reduce your reaction to dust by washing your bedding in hot water at least once a week.
And choose pillows that contain synthetics... rather than feathers.... because dust mites love feathers.
We have much more from Dr. Tarbox on preventing allergies. Just watch our special interview here.
Related Stories
Willed Body Memorial Service Honors Those Who Donated
On Memorial Day each May, a service is conducted at the Texas Tech University Health Sciences Center Institute of Anatomical Sciences to pay respect to the Willed Body Program donors and their families.
Molecular Pathology Preceptorship: Unmatched Value and Experience
Ericka Hendrix, PhD, MB(ASCP)CM, Program Director and Associate Professor in the Master of Science in Molecular Pathology program in the School of Health Professions spoke about the program’s preceptorship.
Moseley Named Permian Basin Regional Dean of the Texas Tech University Health Sciences Center School of Nursing
Kelly Moseley, DHSc, R.N., has been named the TTUHSC School of Nursing regional dean in the Permian Basin.
Recent Stories
TTUHSC Teams Selected for 2025 Innosphere Life Sciences Accelerator Cohort
A pair of teams representing TTUHSC earned a spot among the 33 startup groups selected for the 2025 cohort of the Innosphere Life Sciences Accelerator.
Exploring New Frontiers in Patient Care
Jenna Kesey, Ph.D., associate managing director for the Clinical Research Institute (CRI) at TTUHSC, said it's important that the university provides opportunities for its patients to have access to innovative therapies through the clinical trial process.
Willed Body Memorial Service Honors Those Who Donated
On Memorial Day each May, a service is conducted at the Texas Tech University Health Sciences Center Institute of Anatomical Sciences to pay respect to the Willed Body Program donors and their families.